Premature ventricular contraction prevention

Revision as of 22:17, 27 April 2020 by Homa Najafi (talk | contribs)
Jump to navigation Jump to search

Premature ventricular contraction Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Premature Ventricular Contraction from other Disorders

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Premature ventricular contraction prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Premature ventricular contraction prevention

CDC onPremature ventricular contraction prevention

Premature ventricular contraction prevention in the news

Blogs on Premature ventricular contraction prevention

to Hospitals Treating Premature ventricular contraction prevention

Risk calculators and risk factors for Premature ventricular contraction prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]

Overview

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].

Secondary Prevention

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include:

  • [Strategy 1]
  • [Strategy 2]
  • [Strategy 3]

Recommendations for Secondary Prevention of SCD in Patients With Ischemic Heart Disease

Class I
1. CPR should be performed in patients in cardiac arrest according to published basic and advanced cardiovascular life support algorithms (Level of Evidence: A).[1][2][3]

2. In patients with hemodynamically unstable VA that persist or recur after a maximal energy shock, intravenous amiodarone should be administered to attempt to achieve a stable rhythm after further defibrillation (Level of Evidence: A). [1][4][5]

3. Patients presenting with VA with hemodynamic instability should undergo direct current cardioversion (Level of Evidence: A).[1][2][3]


References

  1. 1.0 1.1 1.2 Link, Mark S.; Berkow, Lauren C.; Kudenchuk, Peter J.; Halperin, Henry R.; Hess, Erik P.; Moitra, Vivek K.; Neumar, Robert W.; O’Neil, Brian J.; Paxton, James H.; Silvers, Scott M.; White, Roger D.; Yannopoulos, Demetris; Donnino, Michael W. (2015). "Part 7: Adult Advanced Cardiovascular Life Support". Circulation. 132 (18 suppl 2): S444–S464. doi:10.1161/CIR.0000000000000261. ISSN 0009-7322.
  2. 2.0 2.1 Stiell, Ian G.; Wells, George A.; Field, Brian; Spaite, Daniel W.; Nesbitt, Lisa P.; De Maio, Valerie J.; Nichol, Graham; Cousineau, Donna; Blackburn, Josée; Munkley, Doug; Luinstra-Toohey, Lorraine; Campeau, Tony; Dagnone, Eugene; Lyver, Marion (2004). "Advanced Cardiac Life Support in Out-of-Hospital Cardiac Arrest". New England Journal of Medicine. 351 (7): 647–656. doi:10.1056/NEJMoa040325. ISSN 0028-4793.
  3. 3.0 3.1 Sasson, Comilla; Rogers, Mary A.M.; Dahl, Jason; Kellermann, Arthur L. (2010). "Predictors of Survival From Out-of-Hospital Cardiac Arrest". Circulation: Cardiovascular Quality and Outcomes. 3 (1): 63–81. doi:10.1161/CIRCOUTCOMES.109.889576. ISSN 1941-7713.
  4. Dorian, Paul; Cass, Dan; Schwartz, Brian; Cooper, Richard; Gelaznikas, Robert; Barr, Aiala (2002). "Amiodarone as Compared with Lidocaine for Shock-Resistant Ventricular Fibrillation". New England Journal of Medicine. 346 (12): 884–890. doi:10.1056/NEJMoa013029. ISSN 0028-4793.
  5. P. J. Kudenchuk, L. A. Cobb, M. K. Copass, R. O. Cummins, A. M. Doherty, C. E. Fahrenbruch, A. P. Hallstrom, W. A. Murray, M. Olsufka & T. Walsh (1999). "Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation". The New England journal of medicine. 341 (12): 871–878. doi:10.1056/NEJM199909163411203. PMID 10486418. Unknown parameter |month= ignored (help)

Template:WH Template:WS